SCHEMBL6715156

SCHEMBL6715156

COC(=O)C(Cc1ccc(OCCNC(=O)OC(C)(C)C)cc1)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
ITGB3 P05106 3/20 0.50
ITGA2B P08514 3/20 0.50
CA12 O43570 2/20 0.49
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
CA9 Q16790 2/20 0.49
IDO1 P14902 1/20 0.48
POLB P06746 1/20 0.47
MAPK1 P28482 1/20 0.47
LTA4H P09960 1/20 0.46
SUCNR1 Q9BXA5 2/20 0.45
BCHE P06276 1/20 0.45
CNR2 P34972 1/20 0.45
SYK P43405 1/20 0.44
PDK2 Q15119 1/20 0.44
PPARG P37231 1/20 0.43
PPARD Q03181 1/20 0.43
PPARA Q07869 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29260893 0.84 ITGB3 (0.66) MAPTL3MBTL1ITGB3ITGA2BPOLB
SCHEMBL25623328 0.83 CA12 (0.62) MAPTL3MBTL1CA12CA1CA2
SCHEMBL30638155 0.82 ITGB3 (0.63) MAPTL3MBTL1ITGB3ITGA2BPOLB
SCHEMBL30572143 0.82 SYK (0.52) MAPTL3MBTL1IDO1POLBMAPK1
SCHEMBL6716145 0.81 ITGB3 (0.75) MAPTL3MBTL1ITGB3ITGA2BSYK
SCHEMBL6716140 0.81 ITGB3 (0.75) MAPTL3MBTL1ITGB3ITGA2BSYK
SCHEMBL30149863 0.81 ITGB3 (0.67) MAPTL3MBTL1ITGB3ITGA2BPOLB
SCHEMBL6716011 0.81 CA12 (0.50) ITGB3ITGA2BCA12CA1CA2
SCHEMBL6714729 0.81 CA12 (0.57) MAPTL3MBTL1ITGB3ITGA2BCA12
SCHEMBL23884216 0.80 MAPT (0.69) MAPTL3MBTL1ITGB3ITGA2BCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 MAPT 4838/4885L3MBTL1 1431/4885ITGB3 2795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.